Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $38.10 million. The enterprise value is $26.67 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 54.25 million shares outstanding. The number of shares has increased by 65.38% in one year.
| Current Share Class | 54.25M |
| Shares Outstanding | 54.25M |
| Shares Change (YoY) | +65.38% |
| Shares Change (QoQ) | +11.04% |
| Owned by Insiders (%) | 6.73% |
| Owned by Institutions (%) | 27.28% |
| Float | 43.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.26 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.69, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.69 |
| Quick Ratio | 10.35 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -131.58% and return on invested capital (ROIC) is -77.76%.
| Return on Equity (ROE) | -131.58% |
| Return on Assets (ROA) | -73.17% |
| Return on Invested Capital (ROIC) | -77.76% |
| Return on Capital Employed (ROCE) | -109.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$348,593 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.84% in the last 52 weeks. The beta is -4.94, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | -4.94 |
| 52-Week Price Change | -54.84% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 43.42 |
| Average Volume (20 Days) | 191,605 |
Short Selling Information
The latest short interest is 138,504, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 138,504 |
| Short Previous Month | 93,305 |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.05M |
| Pretax Income | -17.47M |
| Net Income | -18.82M |
| EBITDA | -17.99M |
| EBIT | -19.05M |
| Earnings Per Share (EPS) | -$0.51 |
Full Income StatementBalance Sheet
The company has $13.10 million in cash and $816,000 in debt, giving a net cash position of $12.28 million or $0.23 per share.
| Cash & Cash Equivalents | 13.10M |
| Total Debt | 816,000 |
| Net Cash | 12.28M |
| Net Cash Per Share | $0.23 |
| Equity (Book Value) | 17.08M |
| Book Value Per Share | 0.32 |
| Working Capital | 12.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.72 million and capital expenditures -$2.49 million, giving a free cash flow of -$18.21 million.
| Operating Cash Flow | -15.72M |
| Capital Expenditures | -2.49M |
| Free Cash Flow | -18.21M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
